Efficacy of Metadoxine Extended Release in Patients With Predominantly Inattentive Subtype Attention-Deficit/Hyperactivity Disorder

References

• . Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med. 2006;36(2):159–165
   PubMed Web of Science ®Google Scholar
• . Kessler RC, Green JG, Adler LA, . Structure and diagnosis of adult attention-deficit/hyperactivity disorder: analysis of expanded symptom criteria from the adult ADHD clinical diagnostic scale. Arch Gen Psychiatry. 2010;67(11):1168–1178
   PubMed Web of Science ®Google Scholar
• . Kessler RC, Adler L, Barkley R, . The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163(4):716–723
   PubMed Web of Science ®Google Scholar
• . Rosier M, Retz W, Retz-Junginger P, . Prevalence of attention deficit-/hyperactivity disorder (ADHD) and comorbid disorders in young male prison inmates. Eur Arch Psychiatry Clin Neurosci. 2004;254(6):365–371
   PubMedGoogle Scholar
• . Biederman J, Faraone SV, Spencer TJ, Mick E, Monuteaux MC. Functional impairments in adults with self-reports of diagnosed ADHD: A controlled study of 1001 adults in the community. J Clin Psychiatry. 2006;67(4):524–540
   PubMed Web of Science ®Google Scholar
• . Faraone SV, Kunwar A, Adamson J, Biederman J. Personality traits among ADHD adults: implications of late-onset and subthreshold diagnoses. Psychol Med. 2009;39(4):685–693
   PubMed Web of Science ®Google Scholar
• . Reimer B, Mehler B, D'Ambrosio LA, Fried R. The impact of distractions on young adult drivers with attention deficit hyperactivity disorder (ADHD). Accid Anal Prev. 2010;42(3):842–851
   PubMed Web of Science ®Google Scholar
• . Biederman J, Arnsten AF, Faraone SV, . New developments in the treatment of ADHD. J Clin Psychiatry. 2006;67(1):148–159
   PubMed Web of Science ®Google Scholar
• . Adler LD, Nierenberg AA. Review of Medication Adherence in Children and Adults with ADHD. Postgrad Med. 2010;122(1):184–191
   PubMed Web of Science ®Google Scholar
• . Wilens TE, Adler LA Adams J, . Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry. 2008;47(1):21–31
   PubMed Web of Science ®Google Scholar
• . Faraone SV, Upadhyaya HP. The effect of stimulant treatment for ADHD on later substance abuse and the potential for medication misuse, abuse, and diversion. J Clin Psychiatry. 2007;68(11):e28
   PubMedGoogle Scholar
• . Faraone SV, Wilens TE. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion. J Clin Psychiatry. 2007;68 ( Suppl 11):15–22
   PubMed Web of Science ®Google Scholar
• . Arria AM, Caldeira KM, O'Grady KE, Vincent KB, Johnson EP, Wish ED. Nonmedical use of prescription stimulants among college students: associations with attention-deficit-hyperactivity disorder and polydrug use. Pharmacotherapy. 2008;28(2):156–169
   PubMed Web of Science ®Google Scholar
• . Strattera. [prescribing information]. Indianapolis, IN: Eli Lilly and Co.; 2011
   Google Scholar
• . Intuniv. [prescribing information]. Wayne, PA: Shire US Inc.; 2011
   Google Scholar
• . Vitamin B6 (pyridoxine and pyridoxal 5′-phosphate) - monograph. Altern Med Rev. 2001;6(1):87–92
   PubMedGoogle Scholar
• . Caballeria J, Pares A, Bru C, . Metadoxine accelerates fatty liver recovery in alcoholic patients: results of a randomized double-blind, placebo-control trial. Spanish Group for the Study of Alcoholic Fatty Liver. J Hepatol. 1998;28(1):54–60
   PubMed Web of Science ®Google Scholar
• . Bono G, Sinforiani E, Merlo P, Belloni G, Soldati M, Gelso E. Alcoholic abstinence syndrome: short-term treatment with metadoxine. Int J Clin Pharmacol Res. 1991;11 (1):35–40
   PubMedGoogle Scholar
• . Shpilenya LS, Muzychenko AP, Gasbarrini G, Addolorato G. Metadoxine in acute alcohol intoxication: a double-blind, randomized, placebo-controlled study. Alcohol Clin Exp Res. 2002;26(3):340–346
   PubMed Web of Science ®Google Scholar
• . Stein MA, Sarampote CS, Waldman ID, . A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder. Pediatrics. 2003;112(5)
   Web of Science ®Google Scholar
• . Stein MA, Waldman ID, Charney E, . Dose effects and comparative effectiveness of extended release dexmethylphenidate and mixed amphetamine salts. J Child Adolesc Psychopharmacol. 2011;21(6):581–588
   PubMed Web of Science ®Google Scholar
• . Manor I, Ben-Hayun R, Aharon-Peretz J, . A randomized, double-blind, placebo-controlled, multicenter study evaluating the efficacy, safety, and tolerability of extended-release metadoxine in adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2012;73(12):1517–1523
   PubMed Web of Science ®Google Scholar
• . Adler L, Cohen J. Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder. Psychiatr Clin North Am. 2004;27(2):187–201
   PubMed Web of Science ®Google Scholar
• . First MB, Spitzer RL, Gibbon M, Williams J. Structured clinical interview for DSM-IV-TR axis I disorders-patient Edition (SCID-I/P). New York, NY: Biometrics Research Department, New York State Psychiatric Institute; 2002
   Google Scholar
• . Guy W. Clinical global impressions. In: Guy W, ed. ECDEU assessment manual for psychopharmacology (revised). Rockville, MD: National Institute of Mental Health; 1976:217–221
   Google Scholar
• . Greenberg LM, Waldmant ID. Developmental Normative Data on The Test of Variables of Attention (T.O.V.A.™). J Child Psychol Psychiatry. 1993;34(6):1019–1030
   PubMed Web of Science ®Google Scholar
• . Brod M, Johnston J, Able S, Swindle R. Validation of the adult attention-deficit/hyperactivity disorder quality-of-life Scale (AAQoL): a disease-specific quality-of-life measure. Qual Life Res. 2006;15(1):117–129
   PubMed Web of Science ®Google Scholar
• . Conners CK, Erhardt D, Sparrow E. Conners' Adult ADHD Rating Scales. North Tonawanda, NY: Multi-Health Systems, Inc.; 1999
   Google Scholar
• . Van Voorhees EE, Hardy KK, Kollins SH. Reliability and validity of self- and other-ratings of symptoms of ADHD in adults. J Atten Disord. 2011;15(3)
   PubMedGoogle Scholar
• . Adler LA, Spencer T, Faraone SV, . Training raters to assess adult ADHD: reliability of ratings. J Atten Disord. 2005;8(3):121–126
   PubMedGoogle Scholar
• . Durell T, Adler L, Wilens T, Paczkowski M, Schuh K. Atomoxetine treatment for ADHD: younger adults compared with older adults. J Atten Disord. 2010;13(4):401–406
   PubMedGoogle Scholar
• . Covey LS, Hu MC, Weissman J, Croghan I, Adler L, Winhusen T. Divergence by ADHD subtype in smoking cessation response to OROS-methylphenidate. Nicotine Tob Res. 2011;13(10):1003–1008
   PubMedGoogle Scholar
• . Michelson D, Buitelaar JK, Danckaerts M, . Relapse prevention in pediatric patients with ADHD treated with atomoxetine: a randomized, double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry. 2004;43(7):896–904
   PubMedGoogle Scholar
• . Durell TM, Adler LA, Williams DW, . Atomoxetine treatment of attention-deficit/hyperactivity disorder in young adults with assessment of functional outcomes: a randomized, double-blind, placebo-controlled clinical trial. J Clin Psychopharmacol. 2013;33(1):45–54
   PubMed Web of Science ®Google Scholar
• . Adler LA, Liebowitz M, Kronenberger W, . Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder. Depress Anxiety. Mar 2009;26(3):212–221
   PubMed Web of Science ®Google Scholar
• . Wilens TE, Adler LA, Weiss MD, . Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders. Drug Alcohol Depend. 2008;96(1–2):145–154
   PubMed Web of Science ®Google Scholar
• . Adler LA, Kroon RA, Stein M, . A translational approach to evaluate the efficacy and safety of the novel AMPA receptor positive allosteric modulator org 26576 in adult attention-deficit/hyperactivity disorder. Biol Psychiatry. 2012;72(11):971–977
   PubMed Web of Science ®Google Scholar
• . Spencer TJ, Adler LA, Weisler RH, Youcha SH. Triple-bead mixed amphetamine salts (SPD465), a novel, enhanced extended-release amphetamine formulation for the treatment of adults with ADHD: A randomized, double-blind, multicenter, placebo-controlled study. J Clin Psychiatry. 2008;69(9):1437–1448
   PubMed Web of Science ®Google Scholar
• . Adler LA, Lynch LR, Shaw DM, . Effectiveness and duration of effect of open-label lisdexamfetamine dimesylate in adults with ADHD. J Atten Disord. 2013;8:8
   Google Scholar
• . Solanto M, Newcorn J, Vail L, Gilbert S, Ivanov I, Lara R. Stimulant drug response in the predominantly inattentive and combined subtypes of attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2009;19(6):663–671
   PubMed Web of Science ®Google Scholar